Albany International Corporation
08/31/2026 | Press release | Distributed by Public on 08/31/2026 07:05
Regulation FD Disclosure, Management Change/Compensation (Form 8-K)
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(a) Leave of Absence of Chief Financial Officer
On August 31, 2026, Albany International Corp. (the "Company") announced that Willard Station, the Company's Chief Financial Officer and principal financial officer, will commence a medical leave of absence effective immediately. During the leave, Mr. Station will not perform the duties of Chief Financial Officer or principal financial officer. The duration of the leave has not been determined.
(b) Appointment of Acting Chief Financial Officer
In connection with Willard Station's leave of absence, also effective August 31, 2026, the Board of Directors of the Company appointed Sean Valashinas, the Company's Controller and Chief Accounting Officer, to serve as the Company's acting principal financial officer in addition to his role as principal accounting officer. Mr. Valashinas, age 55, has served as Controller and Chief Accounting Officer at the Company since June 9, 2025. Prior to joining the Company, Mr. Valashinas served as Vice President, Accounting, Treasury, and Tax at Resonetics, a leading manufacturer in the medical device industry. Prior to that, Mr. Valashinas worked for Standex International Corporation, a publicly traded global industrial manufacturing company, from 2007 to 2024, and was its Vice President, Chief Accounting Officer & Assistant Treasurer. Mr. Valashinas is a Certified Public Accountant, who holds an Accounting degree from the University of Scranton, and received an MBA from Boston University.
There are no familial relationships or related party transactions with the Company that would require disclosure under Items 401(d) or 404(a) of Regulations S-K in connection with his appointment.
There are no changes to Mr. Valashinas compensation terms.
Item 7.01 Regulation FD Disclosure
On August 31, 2026, the Company issued a press release announcing Willard Station's leave of absence and the appointment of Sean Valashinas as acting Chief Financial Officer.
A copy of the Press Release is attached as Exhibit 99.1 and is hereby incorporated by reference into this Item 7.01. The information contained in this Current Report on Form 8-K, including Exhibit 99.1 furnished herewith, is being furnished and shall not be deemed "filed" for any purpose, including for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section and shall not be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing, except to the extent expressly stated in such filing.
Albany International Corporation published this content on August 31, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on August 31, 2026 at 13:06 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]